Search results
Results from the WOW.Com Content Network
The following is an incomplete list of office-supply companies in the United States. 0–9. 3M [1] A–M. A. B. Dick Company; A. T. Cross Company; ACCO Brands;
Pharmaceutical sales representatives or Medical sales respresentatives [1] are salespeople employed by pharmaceutical companies to persuade doctors to prescribe their drugs to patients. Drug companies in the United States spend ~$5 billion annually sending representatives to doctors, [ 2 ] to provide product information, answer questions on ...
Fortune 500 companies based in Houston [1]: Rank Company name 12: ExxonMobil: 48: Phillips 66: 60: Sysco: 105: Enterprise Products Partners: 106: Hewlett Packard Enterprise: 127: Plains GP Holdings
Catalent, Inc. (Catalent Pharma Solutions), is an American multinational company, and a subsidiary of Novo Holdings A/S since 2024. It is headquartered in Somerset, New Jersey . It is a provider of drug delivery technologies, drug development , drug manufacturing , biologics , gene therapy , and consumer health products.
The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. [ 2 ] [ 3 ] With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company.
The global office supplies market, valued at USD 151.46 billion in 2022, is projected to witness a 2.1% compound annual growth rate (CAGR) from 2023 to 2030. [3] The industry's expansion is attributed to the flourishing global services sector and increased product consumption in education.
In 1986, the company's revenues amounted to $180 million. Its mail-order business was the most successful within the office supplies market, with more than 40 million catalogues and flyers sent to a customer base of approximately 600,000 businesses and organizations, and listing more than 9,000 various office supplies and products.
IMS Health's products and services were used by companies to develop commercialization plans [10] and portfolio strategies, [11] to select patient and physician populations for specific therapies, and to measure the effectiveness of pharmaceutical marketing and sales resources. [12]